Survey of Ophthalmology
Volume 50, Issue 4 , Pages 364-388 , July 2005

Acute Anterior Uveitis and HLA-B27

  • John H. Chang, BSc(Med), MBBS(Hons)

      Affiliations

    • Laboratory of Ocular Immunology, Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney
    • Department of Ophthalmology, St. Vincent's Hospital, Sydney
    • ,
  • Peter J. McCluskey, MD, FRANZCO, FRACS

      Affiliations

    • Laboratory of Ocular Immunology, Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney
    • Department of Ophthalmology, St. Vincent's Hospital, Sydney
    • Department of Ophthalmology, Royal Prince Alfred Hospital, Sydney, Australia
    • ,
  • Denis Wakefield, MD, FRACP, FRCPA

      Affiliations

    • Laboratory of Ocular Immunology, Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney
    • Department of Ophthalmology, St. Vincent's Hospital, Sydney
    • Corresponding Author InformationReprint address: Prof. Denis Wakefield, MD, FRACP, FRCPA, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

References 

  1. Abi-Hanna D, McCluskey P, Wakefield D. HLA antigens in the iris and aqueous humor gamma interferon levels in anterior uveitis. Invest Ophthalmol Vis Sci. 1989;30:990–994
  2. Abi-Hanna D, Wakefield D. Expression of HLA antigens on the human uvea. Br J Rheumatol. 1988;27:68–71
  3. Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. In vivo expression in human eyes. Transplantation. 1988;45:610–613
  4. Adamus G, Amundson D, Vainiene M, et al. Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res. 1996;44:513–518
  5. Adamus G, Manczak M, Sugden B, et al. Epitope recognition and T cell receptors in recurrent autoimmune anterior uveitis in Lewis rats immunized with myelin basic protein. J Neuroimmunol. 2000;108:122–130
  6. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999;162:5045–5048
  7. Baatz H, Puchta J, Reszka R, Pleyer U. Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis. Exp Eye Res. 2001;73:101–109
  8. Baggia S, Lyons JL, Angell E, et al. A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA-B27 expression. J Investig Med. 1997;45:295–301
  9. Bakker M, Grumet FC, Feltkamp TE, Kijlstra A. HLA-antigens in the human uvea. Doc Ophthalmol. 1986;61:271–279
  10. Banares A, Hernandez-Garcia C, Fernandez-Gutierrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am. 1998;24:771–84, ix
  11. Banares AA, Jover JA, Fernandez-Gutierrez B, et al. Bowel inflammation in anterior uveitis and spondyloarthropathy. J Rheumatol. 1995;22:1112–1117
  12. Barnett ML, Kremer JM, St Clair EW, et al. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 1998;41:290–297
  13. Bayen H, Bayen MC, De Curzon HP, et al. [Involvement of the posterior eye segment in HLA B27(+) iridocyclitis. Incidence. Value of surgical treatment]. J Fr Ophtalmol. 1988;11:561–566
  14. Becker MD, Rosenbaum JT. Current and future trends in the use of immunosuppressive agents in patients with uveitis. Curr Opin Ophthalmol. 2000;11:472–477
  15. Beckingsale AB, Davies J, Gibson JM, Rosenthal AR. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27. Br J Ophthalmol. 1984;68:741–745
  16. Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Banares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye. 2000;14:340–343
  17. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990;11:137–142
  18. Bhattacherjee P, Williams RN, Eakins KE. An evaluation of ocular inflammation following the injection of bacterial endotoxin into the rat foot pad. Invest Ophthalmol Vis Sci. 1983;24:196–202
  19. Biswas J, Narain S, Das D, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996;20:223–228
  20. Boisgerault F, Tieng V, Stolzenberg MC, et al. Differences in endogenous peptides presented by HLA-B∗2705 and B∗2703 allelic variants. Implications for susceptibility to spondylarthropathies. J Clin Invest. 1996;98:2764–2770
  21. Bora NS, Kim MC, Kabeer NH, et al. Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci. 1995;36:1056–1066
  22. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998;41:58–67
  23. Breban M, Fernandez-Sueiro JL, Richardson JA, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol. 1996;156:794–803
  24. Breban M, Hammer RE, Richardson JA, Taurog JD. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med. 1993;178:1607–1616
  25. Breban M, Vignon E, Claudepierre P, et al. Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford). 2002;41:1280–1285
  26. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet. 1973;2:994–996
  27. Brewerton DA, Caffrey M, Nicholls A, et al. Reiter's disease and HL-A 27. Lancet. 1973;2:996–998
  28. Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904–907
  29. Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp Eye Res. 1992;55:401–411
  30. Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uveitis (EAAU). III. Induction by immunization with purified uveal and skin melanins. Exp Eye Res. 1993;56:575–583
  31. Brown MA, Jepson A, Young A, et al. Ankylosing spondylitis in West Africans—evidence for a non-HLA-B27 protective effect. Ann Rheum Dis. 1997;56:68–70
  32. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823–1828
  33. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59:883–886
  34. Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 1998;41:588–595
  35. Burney RO, Pile KD, Gibson K, et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis. 1994;53:58–60
  36. Calder VL, Shaer B, Muhaya M, et al. Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest Ophthalmol Vis Sci. 1999;40:2019–2024
  37. Careless DJ, Chiu B, Rabinovitch T, et al. Immunogenetic and microbial factors in acute anterior uveitis. J Rheumatol. 1997;24:102–108
  38. Chan CC, Detrick B, Nussenblatt RB, et al. HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch Ophthalmol. 1986;104:725–729
  39. Chan CC, Hikita N, Dastgheib K, et al. Experimental melanin-protein-induced uveitis in the Lewis rat. Immunopathologic processes. Ophthalmology. 1994;101:1275–1280
  40. Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci. 2004;45:1871–1878
  41. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263–279
  42. Chen BP, Madrigal A, Parham P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med. 1990;172:779–788
  43. Colbert RA. HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?. Mol Med Today. 2000;6:224–230
  44. Colbert RA, Prahalad S. Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27. Curr Rheumatol Rep. 2001;3:404–411
  45. Dandona L, Dandona R, John RK, et al. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol. 2000;84:706–709
  46. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Arch Ophthalmol. 1962;68:502–515
  47. de Vos AF, Dick AD, Klooster J, et al. Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis. Invest Ophthalmol Vis Sci. 2000;41:3001–3010
  48. de Vos AF, Klaren VN, Kijlstra A. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35:3873–3883
  49. De Vos AF, Klaren VN, Kijlstra A. Simultaneous induction of cytokine mRNA expression in the anterior uvea during endotoxin-induced uveitis in the rat. Exp Eye Res. 1996;62:581–584
  50. de Vos AF, van Haren MA, Verhagen C, et al. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35:1100–1106
  51. Derhaag PJ, de Waal LP, Linssen A, Feltkamp TE. Acute anterior uveitis and HLA-B27 subtypes. Invest Ophthalmol Vis Sci. 1988;29:1137–1140
  52. Derhaag PJ, Linssen A, Broekema N, et al. A familial study of the inheritance of HLA-B27-positive acute anterior uveitis. Am J Ophthalmol. 1988;105:603–606
  53. Derhaag PJ, van der Horst AR, de Waal LP, Feltkamp TE. HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex. Invest Ophthalmol Vis Sci. 1989;30:2160–2164
  54. Detrick B, Rodrigues M, Chan CC, et al. Expression of HLA-DR antigen on retinal pigment epithelial cells in retinitis pigmentosa. Am J Ophthalmol. 1986;101:584–590
  55. Dodds EM, Lowder CY, Meisler DM. Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm. 1999;7:85–92
  56. Dougados M, Berenbaum F, Maetzel A, Amor B. Prevention des episodes d'uveite anterieure aigue des spondylarthropathies par la salazosulfapyridine. Rev Rhum Ed Fr. 1993;60:81–83
  57. Edwards JC, Bowness P, Archer JR. Jekyll and Hyde: the transformation of HLA-B27. Immunol Today. 2000;21:256–260
  58. Ehlers N, Kissmeyer-Nielsen F, Kjerbye KE, Lamm LU. Letter: HL-A27 in acute and chronic uveitis. Lancet. 1974;1:99
  59. El-Shabrawi Y, Hermann J. Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology. 2002;109:2342–2346
  60. El-Shabrawi Y, Hermann J. Case series of selective anti-tumor necrosis factor alpha therapy using infliximab in patients with nonresponsive chronic HLA-B27-associated anterior uveitis: comment on the articles by Brandt et al. Arthritis Rheum. 2002;46:2821–2822author reply 2822–4
  61. El-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmology. 1998;105:1659–1663
  62. Falgarone G, Blanchard HS, Riot B, et al. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun. 1999;67:3773–3779
  63. Feltkamp TE. Ophthalmological significance of HLA associated uveitis. Eye. 1990;4:839–844
  64. Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA-DRB1∗0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol. 1998;59:183–188
  65. Goto K, Ota M, Ando H, et al. MICA gene polymorphisms and HLA-B27 subtypes in Japanese patients with HLA-B27-associated acute anterior uveitis. Invest Ophthalmol Vis Sci. 1998;39:634–637
  66. Goto K, Ota M, Maksymowych WP, et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol. 1998;126:436–441
  67. Granfors K, Jalkanen S, Lindberg AA, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990;335:685–688
  68. Granfors K, Jalkanen S, Toivanen P, et al. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol. 1992;19:500
  69. Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989;320:216–221
  70. Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol. 1993;151:5751–5761
  71. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500
  72. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 2001;62:1191–1199
  73. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63:1099–1112
  74. Hayashi S, Guex-Crosier Y, Delvaux A, et al. Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis. Graefes Arch Clin Exp Ophthalmol. 1996;234:633–636
  75. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131–136
  76. Herbort CP, Chan CC, Nussenblatt RB. Endotoxin-induced uveitis in the rat: a hypothesis for preferential involvement of the anterior uvea. Curr Eye Res. 1990;9(Suppl):119–124
  77. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993;342:646–650
  78. Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol. 1988;140:440–445
  79. Hohol MJ, Khoury SJ, Cook SL, et al. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Ann NY Acad Sci. 1996;778:243–250
  80. Holland GN, Cornell PJ, Park MS, et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Am J Ophthalmol. 1989;108:370–374
  81. Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol. 2000;84:413–416
  82. Huhtinen M, Laasila K, Granfors K, et al. Infectious background of patients with a history of acute anterior uveitis. Ann Rheum Dis. 2002;61:1012–1016
  83. Ikawa T, Ikeda M, Yamaguchi A, et al. Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium. J Clin Invest. 1998;101:263–272
  84. Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 1994;35:3890–3896
  85. Jardetzky TS, Lane WS, Robinson RA, et al. Identification of self peptides bound to purified HLA-B27. Nature. 1991;353:326–329
  86. Jerdan JA, Pepose JS, Michels RG, et al. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology. 1989;96:801–810
  87. Joseph A, Raj D, Dua HS, et al. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology. 2003;110:1449–1453
  88. Kaijzel EL, Brinkman BM, van Krugten MV, et al. Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol. 1999;60:140–144
  89. Kapasi K, Inman RD. HLA-B27 expression modulates Gram-negative bacterial invasion into transfected L cells. J Immunol. 1992;148:3554–3559
  90. Keat A, Thomas B, Dixey J, et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987;1:72–74
  91. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263–269
  92. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136:896–907
  93. Khan MA. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol. 2000;12:235–238
  94. Khare SD, Bull MJ, Hanson J, et al. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol. 1998;160:101–106
  95. Khare SD, Hansen J, Luthra HS, David CS. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996;98:2746–2755
  96. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995;182:1153–1158
  97. Kijlstra A, Luyendijk L, van der Gaag R, et al. IgG and IgA immune response against klebsiella in HLA-B27-associated anterior uveitis. Br J Ophthalmol. 1986;70:85–88
  98. Kim MC, Kabeer NH, Tandhasetti MT, et al. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1995;14:703–710
  99. Kim MH, Seong MC, Kwak NH, et al. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol. 2000;129:173–177
  100. Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med. 2000;343:782–786
  101. Kogiso M, Tanouchi Y, Mimura Y, et al. Endotoxin-induced uveitis in mice. 1. Induction of uveitis and role of T lymphocytes. Jpn J Ophthalmol. 1992;36:281–290
  102. Konno Y, Numaga J, Mochizuki M, et al. TAP polymorphism is not associated with ankylosing spondylitis and complications with acute anterior uveitis in HLA-B27-positive Japanese. Tissue Antigens. 1998;52:478–483
  103. Konno Y, Numaga J, Tsuchiya N, et al. HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis. Invest Ophthalmol Vis Sci. 1999;40:1838–1844
  104. Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1997;235:5–9
  105. Koumantaki Y, Stavropoulos C, Spyropoulou M, et al. HLA-B∗5101 in Greek patients with Behcet's disease. Hum Immunol. 1998;59:250–255
  106. Lacomba MS, Martin CM, Chamond RR, et al. Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol. 2000;118:768–772
  107. Laitio P, Virtala M, Salmi M, et al. HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol. 1997;27:1331–1338
  108. Lamas JR, Brooks JM, Galocha B, et al. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27. Int Immunol. 1998;10:259–266
  109. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001;68:918–926
  110. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44:653–657
  111. Li Q, Peng B, Whitcup SM, et al. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res. 1995;61:629–632
  112. Lightman S. New therapeutic options in uveitis. Eye. 1997;11:222–226
  113. Linssen A. B27+ disease versus B27− disease. Scand J Rheumatol. 1990;87(Suppl):111–118discussion 118–9
  114. Linssen A, Dekker-Saeys AJ, Dandrieu MR, et al. Possible ankylosing spondylitis in acute anterior uveitis. Br J Rheumatol. 1983;22:137–143
  115. Linssen A, Dekker-Saeys AJ, Dijkstra PF, et al. The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands. Doc Ophthalmol. 1986;64:217–223
  116. Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol. 1995;120:351–361
  117. Linssen A, Rothova A, Valkenburg HA, et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci. 1991;32:2568–2578
  118. Liu Y, Penttinen MA, Granfors K. Insights into the Role of Infection in the Spondyloarthropathies. Curr Rheumatol Rep. 2001;3:428–434
  119. Liversidge JM, Sewell HF, Forrester JV. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol. 1988;73:489–494
  120. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763–769
  121. Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature. 1991;353:321–325
  122. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 1992;70:1035–1048
  123. Maki-Ikola O, Lehtinen K, Toivanen P, Granfors K. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis. Br J Rheumatol. 1995;34:418–420
  124. Maksymowych WP, Jhangri GS, Gorodezky C, et al. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis. 1997;56:488–492
  125. Maksymowych WP, Wessler A, Schmitt-Egenolf M, et al. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol. 1994;21:665–669
  126. Mapstone R, Woodrow JC. HL-A 27 and acute anterior uveitis. Br J Ophthalmol. 1975;59:270–275
  127. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. 2005;52:269–274
  128. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35–46
  129. McMenamin PG, Crewe J. Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body. Invest Ophthalmol Vis Sci. 1995;36:1949–1959
  130. McMenamin PG, Crewe J, Kijlstra A. Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU). Ocul Immunol Inflamm. 1997;5:223–233
  131. Mear JP, Schreiber KL, Munz C, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol. 1999;163:6665–6670
  132. Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385–390
  133. Meredith TA, Smith RE, Duquesnoy RJ. Association of HLA-DRw2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol. 1980;89:70–76
  134. Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curr Eye Res. 1997;16:865–874
  135. Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702–3708
  136. Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum. 2002;46:1430–1438
  137. Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802–809
  138. Monowarul Islam SM, Numaga J, Fujino Y, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 1995;38:547–550
  139. Mugnier B, Balandraud N, Darque A, et al. Polymorphism at position −308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum. 2003;48:1849–1852
  140. Nussenblatt RB. National Institute of Health Report of the National Advisory Eye Council support for visual research. Washington, DC: US Department of Health. Education and Welfare; 1976;
  141. Nussenblatt RB, Caspi RR, Mahdi R, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990;144:1689–1695
  142. Nussenblatt RB, Gery I, Weiner HL, et al. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol. 1997;123:583–592
  143. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147–158
  144. Nussenblatt RB, Whitcup SM, de Smet MD, et al. Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. Ann NY Acad Sci. 1996;778:325–337
  145. Ohno S. Immunological aspects of Behcet's and Vogt-Koyanagi-Harada's diseases. Trans Ophthalmol Soc UK. 1981;101:335–341
  146. Okumura A, Mochizuki M. Endotoxin-induced uveitis in rats: morphological and biochemical study. Jpn J Ophthalmol. 1988;32:457–465
  147. Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ. The association of HLA class II with pars planitis. Am J Ophthalmol. 2001;131:657–659
  148. Osusky R, Dorio RJ, Arora YK, et al. MHC class II positive retinal pigment epithelial (RPE) cells can function as antigen-presenting cells for microbial superantigen. Ocul Immunol Inflamm. 1997;5:43–50
  149. Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75:76–81
  150. Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Saari KM. Uveitis survey at the University Eye Clinic in Turku. Acta Ophthalmologica. 1994;72:505–512
  151. In:  Parham P editors. Pathways of antigen processing and presentation, vol. 172. Copenhagen: Denmark: Munksgaard; 1999;
  152. Parham P. Structure of class-I MHC molecules: HLA-B27 and disease. Scand J Rheumatol. 1990;87(Suppl):11–20
  153. Pato E, Banares A, Jover JA, et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol. 2000;27:2198–2202
  154. Percopo CM, Hooks JJ, Shinohara T, et al. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol. 1990;145:4101–4107
  155. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci. 1994;35:924–930
  156. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998;105:1646–1651
  157. Priem HA, Kijlstra A, Noens L, et al. HLA typing in birdshot chorioretinopathy. Am J Ophthalmol. 1988;105:182–185
  158. Queiro R, Sarasqueta C, Belzunegui J, et al. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum. 2002;31:413–418
  159. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106:594–599
  160. Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46:1–18
  161. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945–953
  162. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum. 2001;44:1411–1415
  163. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol. 2001;13:265–272
  164. Ringrose JH. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?. Ann Rheum Dis. 1999;58:598–610
  165. Robinson J, Waller MJ, Parham P, et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucl Acids Res. 2003;31:311–314
  166. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today. 1996;17:131–137
  167. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994;101:1267–1274
  168. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593–599
  169. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am. 1992;18:143–151
  170. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol. 1989;16:792–796
  171. Rosenbaum JT. HLA B27-associated diseases. In:  Pepose JS,  Holland GN,  Wilhelmus KR editor. Ocular Infection and Immunity. St Louis: Mosby-Yearbook; 1996;p. 475–484
  172. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980;286:611–613
  173. Rothova A, Buitenhuis HJ, Christiaans BJ, et al. Acute anterior uveitis (AAU) and HLA-B27. Br J Rheumatol. 1983;22:144–145
  174. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76:137–141
  175. Rothova A, Kijlstra A, Buitenhuis HJ, et al. HLA-B27 associated uveitis. A distinct clinical entity?. In:  Saari KM editors. Uveitis Update. Amsterdam: Elsevier Science Publishers; 1984;p. 91–95
  176. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332–336
  177. Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103:137–145
  178. Ruiz-Moreno JM, Thillaye B, de Kozak Y. Retino-choroidal changes in endotoxin-induced uveitis in the rat. Ophthalmic Res. 1992;24:162–168
  179. Saari KM, Laitinen O, Leirisalo M, Saari R. Ocular inflammation associated with Yersinia infection. Am J Ophthalmol. 1980;89:84–95
  180. Saari KM, Solja J, Hakli J, et al. Genetic background of acute anterior uveitis. Am J Ophthalmol. 1981;91:711–720
  181. Saari KM, Vilppula A, Lassus A, et al. Ocular inflammation in Reiter's disease after Salmonella enteritis. Am J Ophthalmol. 1980;90:63–68
  182. Saari R, Lahti R, Saari KM, et al. Frequency of rheumatic diseases in patients with acute anterior uveitis. Scand J Rheumatol. 1982;11:121–123
  183. Saarinen M, Ekman P, Ikeda M, et al. Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology. 2002;41:651–657
  184. Said-Nahal R, Miceli-Richard C, Gautreau C, et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. [comment] Ann Rheum Dis. 2002;61:201–206
  185. Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33:251–255
  186. Sasaki T, Kusaba Y, Yamamoto T, et al. HLA-B27 and acute anterior uveitis in the Japanese population. Jpn J Ophthalmol. 1979;23:374–377
  187. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704–706
  188. Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166:173–181
  189. Scofield RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci USA. 1993;90:9330–9334
  190. Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet. 2001;358:295–296
  191. Shindo Y, Ohno S, Usui M, et al. Immunogenetic study of sympathetic ophthalmia. Tissue Antigens. 1997;49:111–115
  192. Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993;17:71–76
  193. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252–257
  194. Stephens HA. MICA and MICB genes: can the enigma of their polymorphism be resolved?. Trends Immunol. 2001;22:378–5
  195. Sugita M, Enomoto Y, Nakaura S, et al. Epidemiological study on endogenous uveitis in Japan. In:  Dernouchamps JP,  Verougstraete C,  Caspers-Velu L,  Tassignon MJ editor. Recent Advances in Uveitis—Proceedings of the Third International Symposium on Uveitis, Brussels, Belgium, 1992. Amsterdam: Kugler Publications; 1993;p. 161–163
  196. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337:1029–1035
  197. Taurog JD, Maika SD, Simmons WA, et al. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol. 1993;150:4168–4178
  198. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359–2364
  199. Taurog JD, Satumtira N, Richardson JA, et al. Alleles of the inbred dark Agouti rat strain are protective against inflammatory disease in HLA-B27 transgenic rats. Arthritis Rheum. 1996;39:S121
  200. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121:47–56
  201. Thompson HS, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol. 1986;64:581–586
  202. Thurau SR, Chan CC, Nussenblatt RB, Caspi RR. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol. 1997;109:370–376
  203. Thurau SR, Diedrichs-Mohring M, Fricke H, et al. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol Lett. 1999;68:205–212
  204. Tran VT, Auer C, Guex-Crosier Y, et al. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18:293–298
  205. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993;261:1727–1730
  206. Treseler PA, Foulks GN, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984;98:763–772
  207. Tuohy VK, Yu M, Yin L, et al. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med. 1999;189:1033–1042
  208. Vadot E, Barth E, Billet P. Epidemiology of uveitis—preliminary results of a prospective study in the Savoy. In:  Saari KM editors. Uveitis Update. Amsterdam: Elsevier Science Publishers; 1984;p. 13–17
  209. Van den Bosch F, Kruithof E, Baeten D, et al. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis. 2000;59:428–433
  210. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Rev Immunol. 2002;2:85–95
  211. Vanderlugt CL, Neville KL, Nikcevich KM, et al. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol. 2000;164:670–678
  212. Verhagen C, Mor F, Cohen IR. T cell immunity to myelin basic protein induces anterior uveitis in Lewis rats. J Neuroimmunol. 1994;53:65–71
  213. Verma MJ, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16:1202–1208
  214. Wakefield D, Dunlop I, McCluskey PJ, Penny R. Uveitis: aetiology and disease associations in an Australian population. Aust NZ J Ophthalmol. 1986;14:181–187
  215. Wakefield D, Easter J, Penny R. Clinical features of HLA-B27 anterior uveitis. Aust J Ophthalmol. 1984;12:191–196
  216. Wakefield D, Easter J, Robinson P, Penny R. Immunological features of HLA-B27 anterior uveitis. Aust J Ophthalmol. 1983;11:15–19
  217. Wakefield D, McCluskey P, Verma M, et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum. 1999;42:1894–1897
  218. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 1991;36:223–232
  219. Wakefield D, Wright J, Penny R. HLA antigens in uveitis. Hum Immunol. 1983;7:89–93
  220. Wang ZY, Qiao J, Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol. 1993;44:209–214
  221. Weiner HL, Friedman A, Miller A, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837
  222. Weiner HL, Mackin GA, Matsui M, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993;259:1321–1324
  223. Weinreich S, Eulderink F, Capkova J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol. 1995;42:103–115
  224. Whitcup SM, Nussenblatt RB. Immunologic mechanisms of uveitis. New targets for immunomodulation. Arch Ophthalmol. 1997;115:520–525
  225. Wildner G, Diedrichs-Mohring M, Thurau SR. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin. Eur J Immunol. 2002;32:299–306
  226. Wildner G, Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol. 1994;24:2579–2585
  227. Willbanks GA, Rootman DS, Jay V, et al. Experimental autoimmune uveitis in HLA-B27 transgenic mice. Hum Immunol. 1997;53:188–194
  228. Wolf MD, Folk JC, Panknen CA, Goeken NE. HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1990;108:698–700
  229. Wordsworth P, Brown M. HLA-B27, ankylosing spondylitis, and the spondyloarthropathies. In:  Calin A,  Taurog J editor. Spondylarthritides. Oxford: Oxford University Press; 1998;p. 179–193
  230. Yamaguchi A, Tsuchiya N, Mitsui H, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum. 1995;38:1672–1677
  231. Yoshida M, Yoshimura N, Hangai M, et al. Interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor gene expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1994;35:1107–1113
  232. Yu DT. Pathogenesis of reactive arthritis. Intern Med. 1999;38:97–101
  233. Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004;50:2246–2254
  234. Zhang JJ, Hamachi M, Hamachi T, et al. The bacterial outer membrane protein that reacts with anti-HLA-B27 antibodies is the OmpA protein. J Immunol. 1989;143:2955–2960
  235. Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1992;113:567–572
  236. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA. 1991;88:10252–10256

 Dr John H. Chang is a recipient of the NH&MRC Medical Postgraduate Research Scholarship (grant 222928). The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(05)00041-X

doi: 10.1016/j.survophthal.2005.04.003

Survey of Ophthalmology
Volume 50, Issue 4 , Pages 364-388 , July 2005

Article Tools

* Image Usage & Resolution